Personalized Medicines In Oncology Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Personalized Medicines in Oncology Market size is estimated to reach $272.1 billion by 2028, growing at a CAGR of 10% during the forecast period 2022-2028.

Personalized medicines are also divided into precision medicines that are manufactured based on molecular profiling and medical imaging of individual patients to expand the effectiveness of cancer treatment. The main purpose of using precision medicine or predictive biomarkers is to tailor the right treatment to the right patient. Several modern sequencing technologies, such as cancer genome sequencing and next-generation sequencing, help to study genes and provide genomic data. Measures such as biomarkers also play an important role in the development of personalized medicines because they are adept at identifying a patient’s response to a particular drug. Chemotherapy, immunotherapy, hormone therapy, and others are commonly used to treat patients with various types of cancer.

Market Segments

By Technology

• Genome Sequencing
• In situ hybridization
• Next-generation sequencing (NGS)
• Microarray
• PCR

By Application

• Targeted therapy
• Pharmacogenomics

By Cancer Type

• Endometrial Cancer
• Breast Cancer
• Esophageal Cancer
• Prostate Cancer
• Lung Cancer
• Neuroendocrine Tumor
• Colorectal Cancer
• Cervical Cancer
• Blood Cancer

Key Players

• Abbott
• Exact Science Corporation
• GE Healthcare
• Illumina
• Celera Diagnostics
• Biogen
• Decode Genetics
• Danaher Corporation
• Novartis
• Genelex Corporation

Scope of the Report

The research study analyzes the global Personalized Medicines In Oncology industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Personalized Medicines In Oncology Market Report

1. What was the Personalized Medicines In Oncology Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Personalized Medicines In Oncology Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Personalized Medicines In Oncology Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.